{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:48:04Z","timestamp":1794876484483,"version":"4.9.1"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec id=\"ab-soi240066-4\"><jats:title>Importance<\/jats:title><jats:p>Ampullary adenocarcinoma (AA) is characterized by clinical and genomic heterogeneity. A previously developed genomic classifier defined biologically distinct phenotypes with greater accuracy than standard histologic classification. External validation is needed before routine clinical use.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240066-5\"><jats:title>Objective<\/jats:title><jats:p>To test external validity of the prognostic value of the hidden genome classifier of AA.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240066-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective cohort study took place at 6 international academic institutions. Consecutive patients (n\u2009=\u2009192) who underwent curative-intent resection of histologically confirmed AA were included. The data were analyzed from January 2005 through July 2020.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240066-7\"><jats:title>Exposures<\/jats:title><jats:p>The multilevel meta-feature regression model previously trained on a prospectively sequenced cohort of 3411 patients (1001 pancreatic adenocarcinoma, 165 distal bile duct adenocarcinoma, and 2245 colorectal adenocarcinoma) was applied to AA sequencing data to quantify the relative proportions of parental cell of origin.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240066-8\"><jats:title>Main Outcome and Measures<\/jats:title><jats:p>Genomic classification was correlated with immunohistologic subtype (intestinal [INT] or pancreatobiliary [PB]) and with overall survival (OS), using the log-rank test and Cox proportional hazard models.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240066-9\"><jats:title>Results<\/jats:title><jats:p>Among 192 patients with AA (median age, 69.0 [IQR, 60.0-74.0] years and 134 were male [64%]), concordance between immunohistologic and genomic subtypes was 55%. Most INT subtype tumors were categorized into the colorectal genomic subtype (43 of 57 [72.9%]). Of the 114 PB subtype tumors, 29 had a pancreatic genomic profile (25.4%) and 24 had a distal bile duct genomic profile (21.1%). Whereas the standard immunohistologic subtypes were not associated with survival (log rank <jats:italic>P<\/jats:italic>\u2009=\u2009.26), predicted genomic probabilities were correlated with survival probability. Genomic scores with higher colorectal probability were associated with higher survival probability; higher pancreatic and distal bile duct probabilities were associated with lower survival probability.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240066-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The AA genomic classifier is reproducible with available molecular testing in a diverse international cohort of patients and improves stratification of the divergent clinical outcomes beyond standard immunohistologic classification. These data provide a molecular classification that may be incorporated into clinical trials for prospective validation.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2024.3588","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T15:18:45Z","timestamp":1726067925000},"page":"1365","source":"Crossref","is-referenced-by-count":6,"title":["Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication"],"prefix":"10.1001","volume":"159","author":[{"given":"Brett L.","family":"Ecker","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Seier","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin M.","family":"Eckhoff","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella N.","family":"Tortorello","sequence":"additional","affiliation":[{"name":"Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Blackburn","sequence":"additional","affiliation":[{"name":"The Kinghorn Cancer Centre, Garvan Institute of Medical Research, 370 Victoria Street, Darlinghurst, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"DeMatteo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Daniel G.","family":"Blazer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Drebin","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Surgery, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Fortuna","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[{"name":"The Kinghorn Cancer Centre, Garvan Institute of Medical Research, 370 Victoria Street, Darlinghurst, Sydney, New South Wales, Australia"},{"name":"Royal North Shore Hospital, Westbourne Street, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Gingras","sequence":"additional","affiliation":[{"name":"Department of Molecular and Human Genetics, Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"Major K.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Lidsky","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nussbaum","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Overman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaswinder S.","family":"Samra","sequence":"additional","affiliation":[{"name":"Royal North Shore Hospital, Westbourne Street, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronglai","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlie S.","family":"Sigel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles M.","family":"Vollmer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Zani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Roses","sequence":"additional","affiliation":[{"name":"Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"soi240066r1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamasurg.2019.1170","article-title":"Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma.","volume":"154","author":"Ecker","year":"2019","journal-title":"JAMA Surg"},{"issue":"1","key":"soi240066r2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00000658-199807000-00013","article-title":"Factors predictive of survival in ampullary carcinoma.","volume":"228","author":"Howe","year":"1998","journal-title":"Ann Surg"},{"issue":"2","key":"soi240066r3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejso.2008.01.030","article-title":"An audit of outcomes of a series of periampullary carcinomas.","volume":"35","author":"Berberat","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"soi240066r4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"soi240066r5","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1245\/s10434-008-9886-1","article-title":"Survival after resection of ampullary carcinoma: a national population-based study.","volume":"15","author":"O\u2019Connell","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"soi240066r6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/MPA.0000000000000112","article-title":"Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.","volume":"43","author":"Robert","year":"2014","journal-title":"Pancreas"},{"issue":"10","key":"soi240066r7","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.","volume":"31","author":"Chang","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"soi240066r8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/modpathol.2016.124","article-title":"Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.","volume":"29","author":"Reid","year":"2016","journal-title":"Mod Pathol"},{"issue":"7","key":"soi240066r9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41416-019-0415-8","article-title":"Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.","volume":"120","author":"Perkins","year":"2019","journal-title":"Br J Cancer"},{"issue":"4","key":"soi240066r10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/biom.13367","article-title":"Using the \u201cHidden\u201d genome to improve classification of cancer types.","volume":"77","author":"Chakraborty","year":"2021","journal-title":"Biometrics"},{"issue":"1","key":"soi240066r11","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/s41467-021-23094-z","article-title":"Mining mutation contexts across the cancer genome to map tumor site of origin.","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat Commun"},{"issue":"21","key":"soi240066r12","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1158\/1078-0432.CCR-21-1906","article-title":"Genome-Derived classification signature for ampullary adenocarcinoma to improve clinical cancer care.","volume":"27","author":"Chakraborty","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"4","key":"soi240066r13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","article-title":"Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation.","volume":"14","author":"Gingras","year":"2016","journal-title":"Cell Rep"},{"issue":"2","key":"soi240066r14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system.","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"10","key":"soi240066r15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.","volume":"38","author":"Ang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"soi240066r16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology.","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"issue":"1","key":"soi240066r17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1245\/s10434-013-3240-y","article-title":"A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.","volume":"21","author":"Collins","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"soi240066r18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12885-019-5548-x","article-title":"Novel biomarkers distinguishing pancreatic head cancer from distal cholangiocarcinoma based on proteomic analysis.","volume":"19","author":"Takenami","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"soi240066r19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic sequencing identifies elf3 as a driver of ampullary carcinoma.","volume":"29","author":"Yachida","year":"2016","journal-title":"Cancer Cell"},{"issue":"7","key":"soi240066r20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","article-title":"Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up.","volume":"28","author":"Zhou","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"soi240066r21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ejso.2015.01.010","article-title":"Prognostic score for recurrence after Whipple\u2019s pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.","volume":"41","author":"Colussi","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"soi240066r22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/SLA.0000000000003177","article-title":"Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: international multicenter cohort study.","volume":"272","author":"Moekotte","year":"2020","journal-title":"Ann Surg"},{"key":"soi240066r23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2407-8-170","article-title":"Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.","volume":"8","author":"Westgaard","year":"2008","journal-title":"BMC Cancer"},{"issue":"8","key":"soi240066r24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"soi240066r25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/SLA.0b013e318190c53e","article-title":"Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.","volume":"248","author":"Morak","year":"2008","journal-title":"Ann Surg"},{"issue":"5","key":"soi240066r26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/SLA.0b013e318156eef3","article-title":"Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.","volume":"246","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"key":"soi240066r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2023.101994","article-title":"Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma.","volume":"51","author":"Boyev","year":"2023","journal-title":"Surg Oncol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2823529\/jamasurgery_ecker_2024_oi_240066_1733854604.02309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:37:23Z","timestamp":1733949443000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2823529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2024.3588","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}